Unfortunately, alanine transaminase (ALT), a routine indicator of liver inflammatory damage, showed a poor performance in nonalcoholic steatohepatitis (NASH) patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.